Clinical Trials
40 trialsNCT00002968 2026-06-01
Edrecolomab in Treating Patients With Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT02912559 2026-06-01
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00217737 2026-05-29
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00079274 2020-05-13
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00096278 2019-07-30
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00000611 2016-04-15
Women's Health Initiative (WHI)
National Heart, Lung, and Blood Institute (NHLBI)
Phase 3 Completed
NCT00499369 2014-07-31
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00008281 2014-01-06
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002692 2013-12-19
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002893 2013-12-19
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00008060 2013-12-19
Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00012389 2013-12-19
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00021281 2013-12-19
Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005586 2013-12-18
Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
National Cancer Institute (NCI)
Phase 3 Completed
NCT00617071 2013-12-18
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00893295 2013-12-18
Increasing Colorectal Cancer Screening in African Americans
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003354 2013-12-04
Conventional Surgery Compared With Laparoscopic-Assisted Surgery in Treating Patients With Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00004150 2013-11-06
High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00062426 2013-11-06
Oxaliplatin and Bevacizumab (Avastinâ„¢) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003835 2013-10-08
Combination Chemotherapy in Treating Patients With Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003063 2013-09-20
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00046995 2013-09-20
Combination Chemotherapy in Treating Patients With Colon Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002793 2013-09-17
Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00182715 2013-09-17
Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00797485 2013-08-26
Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002455 2013-08-07
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00031863 2013-08-02
Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00559858 2013-08-02
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00427570 2013-06-24
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT00005036 2013-05-03
Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00005094 2013-04-12
Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
National Cancer Institute (NCI)
Phase 3 Completed
NCT00070122 2013-01-25
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00003873 2013-01-24
Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00025337 2013-01-24
Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated
National Cancer Institute (NCI)
Phase 3 Completed
NCT00004931 2013-01-14
Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00020501 2012-03-08
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00006479 2011-04-18
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00091312 2009-02-09
Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003260 2009-01-13
Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00006468 2009-01-13
Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 3 Unknown